Hangzhou Biotest Biotech Co Ltd (688767) — Free Cash Flow Generation Index
Hangzhou Biotest Biotech Co Ltd (688767) has a Free Cash Flow Generation Index of -0.66x as of September 2025. Free cash flow of CN¥-18.63 Million represents -1% of operating cash flow (CN¥28.39 Million). Explore capital reinvestment ratio of Hangzhou Biotest Biotech Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hangzhou Biotest Biotech Co Ltd Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Hangzhou Biotest Biotech Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see Hangzhou Biotest Biotech Co Ltd cash flow conversion.
Annual Free Cash Flow Generation for Hangzhou Biotest Biotech Co Ltd (2017–2025)
Year-by-year Free Cash Flow Generation Index for Hangzhou Biotest Biotech Co Ltd. Check Hangzhou Biotest Biotech Co Ltd (688767) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.22x | CN¥-23.40 Million | CN¥106.47 Million | CN¥129.87 Million | ▲ +75.6% |
| 2024 | -0.90x | CN¥-116.23 Million | CN¥128.83 Million | CN¥245.05 Million | ▼ -258.1% |
| 2023 | 0.57x | CN¥74.96 Million | CN¥131.38 Million | CN¥56.42 Million | ▼ -23.5% |
| 2022 | 0.75x | CN¥524.29 Million | CN¥703.21 Million | CN¥178.92 Million | ▼ -4.4% |
| 2021 | 0.78x | CN¥707.92 Million | CN¥908.12 Million | CN¥200.20 Million | ▼ -10.5% |
| 2020 | 0.87x | CN¥388.38 Million | CN¥446.07 Million | CN¥57.68 Million | ▲ +261.9% |
| 2019 | -0.54x | CN¥-13.81 Million | CN¥25.67 Million | CN¥39.47 Million | ▼ -233.9% |
| 2018 | 0.40x | CN¥8.50 Million | CN¥21.17 Million | CN¥12.67 Million | ▲ +114.7% |
| 2017 | -2.73x | CN¥-19.30 Million | CN¥7.07 Million | CN¥26.37 Million | — |